Home --> Technologies --> Glucosamine

Microbial Production of Glucosamine


Glucosamine is a nutraceutical sold as a dietary supplement to treat symptoms of osteoarthritis and joint pain. Glucosamine is currently produced by the acid hydrolysis of chitin, a process limited by poor yields and the availability of raw materials, for example, crab shells.

This technology provides the capability, by E. coli fermentation, to produce N-acetylglucosamine (NAG) for conversion to glucosamine salts at a cost fully competitive to that of shell-fish sourced material while eliminating supply seasonality issues and regular raw material supply shocks that are regularly afflict the shell-fish supply chain. Note that the rights to produce and use NAG as a chemical intermediate for the production of products other than glucosamine salts are not included in this offering.



Technology Status

Availability and Territory

Patent Status


Tom Jerrell, President
Bio-Technical Resources
Email: jerrell@biotechresources.com
Phone: 920-684-5518
Fax: 920-684-5519



About Us | Services | Resources | Technologies: Glucosamine/NAG |
Site Map | Contact BTR | User Agreement | Privacy Policy

©2014 Bio-Technical Resources, all rights reserved